Project Collabri for Treatment of Anxiety
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether treatment of patients with anxiety according to the Collabri Model is more effective in reducing symptoms compared to treatment as usual (TAU)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Background:
Depression and anxiety are common diseases often treated in general practice. However, there are obstacles for optimal treatment e.g. a lack of continuity in disease management, organized collaboration between primary and secondary care and access to psychotherapy. Previous collaborative care studies have shown significant improvements in treatment outcomes for patients with depression and anxiety in primary care; however studies have yet not been carried out in a Danish context. Thus, the Collabri-model for collaborative care for panic disorder, generalized anxiety, social phobia and depression has been developed. The model includes: a multi-professional approach to treatment including a care manager (e.g. a psychiatric nurse), enhanced inter-professional communication, scheduled monitoring and review and structured treatment plans.
Objective:
To investigate whether treatment according to the Collabri-model have an effect on symptoms for people with anxiety disorders.
Methods/design:
Three cluster-randomized, clinical trials are set up to investigate treatment according to the Collabri-model compared to treatment as usual for 364 patients diagnosed with panic disorder, generalized anxiety and social phobia respectively from general practices in the Capital Region of Denmark. For all studies, the primary outcome is anxiety symptoms measured with Beck Anxiety Inventory (BAI) at 6 months.
Results/discussion:
The results will contribute new knowledge on collaborative care for depression and anxiety disorders in Danish conditions.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Treatment according to the Collabri model Participants in this group will recive treatment according to the Collabri model which is a Danish model for collaborative care between primary and secondary care for depression, social phobia, generalized anxiety and panic disorder |
Other: Treatment according to the Collabri model
The Collabri Model is a complex intervention and consists of a number of treatment modalities. The Collabri Model includes the following elements: A multi-professional approach to treatment including a care manager, scheduled monitoring and review, enhanced inter-professional communication and a structured treatment plan. It further integrates: Recruitment of staff with psychiatric experience, training of general practitioner and care manager, use of instruments for detection and follow-up, education and treatment of the patient, supervision from a psychiatric specialist, guided self-help, patient- and relative involvement and a stepped care approach to treatment where treatment is always commenced on the least invasive and least resource-demanding level.
|
| No Intervention: Treatment as usual Control group. Participants in this group will recive treatment as usual. This means that participants will recive treatment corresponding to what their GP normally would offer as treatment. E.g. this could be refferal to a psychologist or psychiatrist and/or medicine. |
Outcome Measures
Primary Outcome Measures
- Degree of anxiety measured by the Beck Anxiety Inventory (BAI) [At 6 months follow up after baseline]
The measure is self-reported
Secondary Outcome Measures
- Degree of depression measured by the Beck Depression Inventory (BDI) [At 6 months follow up after baseline]
The measure is self-reported
- Psychological stress measured with the Symptom Checklist (SCL-92) [At 6 months follow up after baseline]
The measure is self-reported
- Functional impairment measured with the Global Assessment of Functioning (GAF-F split version) [At 6 months follow up after baseline]
The measure is obtained through a semi-structured interview
Other Outcome Measures
- Degree of anxiety measured by the Beck Anxiety Inventory (BAI) [At 15 months follow up after baseline]
The measure is self-reported
- Degree of depression measured by the Beck Depression Inventory (BDI) [At 15 months follow up after baseline]
The measure is self-reported
- Psychological stress measured with the Symptom Checklist (SCL-92) [At 15 months follow up after baseline]
The measure is self-reported
- Functional impairment measured with the Global Assessment of Functioning (GAF-F split version) [At 15 months follow up after baseline]
The measure is obtained through a semi-structured interview
- Quality of life measured with the WHO-5 scale [At 6 months follow up after baseline]
The measure is self-reported
- Quality of life measured with the WHO-5 scale [At 15 months follow up after baseline]
The measure is self-reported
- Personal and social performance measured with the Personal and Social Performance scale (PSP) [At 6 months follow up after baseline]
The measure is obtained through a semi-structured interview
- Personal and social performance measured with the Personal and Social Performance scale (PSP) [At 15 months follow up after baseline]
The measure is obtained through a semi-structured interview
- Side effects measured by the PRISE questionnaire [At 6 months follow up after baseline]
The measure is self-reported
- Side effects measured by the PRISE questionnaire [At 15 months follow up after baseline]
The measure is self-reported
- Health-related quality of life measured with the EQ-5D [At 6 months follow up after baseline]
The measure is self-reported
- Health-related quality of life measured with the EQ-5D [At 15 months follow up after baseline]
The measure is self-reported
- Functional impairment measured with Sheehan Disability Scale (SDS) [At 6 months follow up after baseline]
The measure is self-reported
- Functional impairment measured with Sheehan Disability Scale (SDS) [At 15 months follow up after baseline]
The measure is self-reported
- Sick leave [At 6 months follow up after baseline]
The measure is obtained from the Danish DREAM database
- Sick leave [At 15 months follow up after baseline]
The measure is obtained from the Danish DREAM database
- Self-efficacy measured with the subscale "Obtain Help from Community, Family, Friends" from the Chronic Disease Self-Efficacy Scale [At 6 months follow up after baseline]
The measure is self-reported
- Self-efficacy measured with the subscale "Obtain Help from Community, Family, Friends" from the Chronic Disease Self-Efficacy Scale [At 15 months follow up after baseline]
The measure is self-reported
- Self-efficacy measured with the subscale "Control/Manage Depression Scale" from the Chronic Disease Self-Efficacy Scale [At 6 months follow up after baseline]
The measure is self-reported
- Self-efficacy measured with the subscale "Control/Manage Depression Scale" from the Chronic Disease Self-Efficacy Scale [At 15 months follow up after baseline]
The measure is self-reported
- Self-efficacy measured with the subscale "Personal Control" from The Revised Illness Perception Questionnaire (IPQ-R) [At 6 months follow up after baseline]
The measure is self-reported
- Self-efficacy measured with the subscale "Personal Control" from The Revised Illness Perception Questionnaire (IPQ-R) [At 15 months follow up after baseline]
The measure is self-reported
- Apathia [At 6 months follow up after baseline]
The measure is obtained through a semi-structured interview
- Apathia [At 15 months follow up after baseline]
The measure is obtained through a semi-structured interview
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age: 18+ years
-
Danish speaking
-
Diagnosis of current depression using the Mini International Neuropsychiatric Interview (MINI) (DSM IV) by researchers that have been trained in using MINI and according to the ICD-10 criteria or when diagnosed by GP after conference with a psychiatrist in Project Collabri
-
The patient has given her/his written informed consent to participate in the trial at the described terms
Exclusion Criteria:
-
High risk of suicide assessed in the Mini International Neuropsychiatric Interview (MINI) and/or by general practitioner
-
Psychotic condition detected in the MINI and/or by general practitioner
-
Patients with a diagnosis of dementia
-
Pregnancy
-
Alcohol or substance misuse that hinders the person participating in Collabri treatment as assessed by the practitioner or researcher at inclusion interview
-
Patients that are in current psychological or psychiatric treatment due to anxiety or depression
-
Patients with a pending disability pension case
-
Patients who have been treated for anxiety or depression within the last 6 months
-
For patients in the intervention group: Patients with depression who wants treatment cf. the Danish psychologist scheme and do not want the reference to the psychologist preceded by other treatment, cf. the Collabri model
-
For patients in the intervention group: If the patient at the first point of contact with the general practitioner after inclusion by a research assistant is referred to treatment as a part of the secondary psychiatric care system.
-
Patients who are assessed by the general practitioner as medically unstable making it impossible for the patient to adhere to treatment
-
OCD, PTSD, bipolar affective disorder as assessed in the MINI and/or by the general practitioner
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Mental Health Centre Copenhagen | Copenhagen | Denmark |
Sponsors and Collaborators
- Mental Health Centre Copenhagen
Investigators
- Principal Investigator: Lene F Eplov, MD PhD, Mental Health Center Copenhagen
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- H-3-2013-203-A